Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Gynecologic 3Genitourinary 2Breast 2Tumor-Agnostic 1

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 542Pemetrexed 392pembrolizumab 372Cisplatin 356Paclitaxel 285Docetaxel 240Gemcitabine 168Nivolumab 158Erlotinib Hydrochloride 147Bevacizumab 114atezolizumab 104osimertinib 99durvalumab 92Etoposide 90Gefitinib 68130-nm albumin-bound paclitaxel 65Cetuximab 64Ipilimumab 60Drug Therapy 51Topotecan 48Injections 44Afatinib 41tislelizumab 40Cyclophosphamide 39Albumin-Bound Paclitaxel 37Vinorelbine 36Crizotinib 34cemiplimab 31icotinib 26Radiotherapy 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × sagopilone × Thoracic × Clear all
NCT00299390 2015-12-31

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Bayer

Phase 2 Terminated
10 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00160069 2014-12-04

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer

Bayer

Phase 2 Completed
128 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00359359 2014-11-04

A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer

Bayer

Phase 1/2 Completed
26 enrolled
Thoracic

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡